Open AccessCorrection: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Author(s) -
Rebecca C. Arend,
Angelina I. Londoño-Joshi,
Abhishek Gangrade,
Ashwini A. Katre,
Chandrika Kurpad,
Yonghe Li,
Rajeev S. Samant,
Pui-Kai Li,
Charles N. Landen,
Eddy S. Yang,
Bertha Hidalgo,
Ronald D. Alvarez,
J. Michael Straughn,
Andres Forero,
Donald J. Buchsbaum
Publication year - 2018
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.25151
Subject(s) - niclosamide , wnt signaling pathway , cancer research , pi3k/akt/mtor pathway , medicine , ovarian cancer , oncology , signal transduction , cancer , biology , microbiology and biotechnology , ecology